You are here: Profiles / Burton J. Goldstein (List of Publications)
Tuesday, 28.03.2017

BURTON J. GOLDSTEIN

LIST OF PUBLICATIONS

  1. Books and monographs published: 

Goldstein BJ.  Drug Responders and Non-Responders in Acute Psychotic Patients.  Proceedings of the IV World Congress of Psychiatry, Madrid, Spain, September, 1966 

Goldstein BJ, Clyde DJ, & Caldwell JM.  Clinical Efficacy of the Butyrophenones as Anti-psychotic Drugs.  Psychopharmacology - A Review of Progress, 1957-1967.  U.S. Government Printing Office, Daniel Effron, Editor, 1968. 

Goldstein BJ, Weiner D, & Banas F.  Clinical Evaluation of Thiothixene in Chronic Ambulatory Schizophrenic Patients.  Modern Medical Problems in Pharmacopsychiatry, Vol. 2.  Basel, Switzerland:  Karger, 1969. 

Goldstein BJ, Brauzer B, & Caldwell JM.  The differential patterns of response to haloperidol and perphenazine.  In Wittenborn, Goldberg and May (Eds.), Psychopharmacology and the Individual Patient.  New York:  Raven Press, pp. 99-105, 1970. 

Goldstein BJ.  Tacitin (Benzoctamine) in the treatment of 120 anxious outpatients.  In P. Kelholz (Ed.), Detente Neuro-Psychique:  Aspects therapeutiques nouveaux.  Basel, Switzerland: CIBA Limited, pp. 67-73, 1970. (Translated into French and German). 

Goldstein BJ.  Symptomatic Volunteers - A new patient treatment model.  Proceedings of the 7th Congress of the Collegium Internationale Neuropharmacologium Excerpta Medica Foundation, June, 1970. 

Goldstein BJ, & Brauzer B.  Pharmacologic considerations in the treatment of anxiety and depression in medical practice.  Medical Clinics of North America, 55(2):485-494, 1971. 

Goldstein BJ.  Academia government - Interrelationships in the development of new psychotropic drugs.  In R. Palmer (Ed.), Controversies in Clinical Pharmacology and Drug Development (Part I).  Mt. Kisco, NY: Futura Publishing Company, pp. 241-253, 1972. 

Goldstein BJ.  Psychotropic medication - A review.  Psychiatry and the Law.  Conger Publications, 1974. 

Goldstein BJ.  In M. Goldberg and J. Egleston (Eds.), Mind Influencing Drugs, Neuroleptic Drugs.  Publishing Sciences Group, 1979. 

Goldstein BJ.  The risk of abuse and dependence of short acting benzodiazepines.  In B. Trabor (Ed.) Benzodiazepines - A Clinical Perspective.  BMI Publications.  (Proceedings of Symposium), 1982.

Rosen H, Goldstein BJ, Dominguez RA.  An Overview of Psychiatric Drugs Used in Clinical Practice.  Review Course:  Fundamental and Clinical Aspects of Internal Medicine.  Copyright by the University of Miami, 1983. 

Dominguez RA, & Goldstein BJ:  Psychotropic drugs for the internist.  Review Course:  Fundamental and Clinical Aspects of Internal Medicine. 

Copyright by the University of Miami, 1986. 

Dominguez RA, Goldstein BJ:  "American experience with the use of Dothiepin." in "Expectations in the treatment of depressive illness:  The role of dothiepin."  Round Table Series, Royal Society of Medicine Service. London, England, pp 8-15. 

Juried or referred journal articles or exhibitions: 

Goldstein BJ:  Prophylactic treatment of Phenothiazine induced Extra pyramidal effects.  Journal of the Florida Medical Association, November, 1964. 

Goldstein BJ:  Haloperidol in controlling the symptoms of acute psychosis:  Part I, A preliminary investigation.  Current Therapeutic Research 8:231-234, 1966. 

Goldstein BJ & Clyde DJ: Haloperidol in controlling the symptoms of acute psychosis.  Part II, a double-blind evaluation of Haloperidol and Trifluoperazine.  Current Therapeutic Research8:235-239, 1966. 

Goldstein BJ:  Scopolamine induced acute brain syndrome.  Journal of the Florida Medical Association 53:413-414, 1966. 

Goldstein BJ & Huston PB:  TPO-33:  A pilot study.  Current Therapeutic Research 9:38-41, 1967. 

Goldstein BJ:  Overview of Haloperidol - a non-phenothiazine neuroleptic.  International Symposium on Haloperidol.  International Journal of Neuropsychiatry 3:1-5, 1967. 

Goldstein BJ:  Double-blind comparison of tybamate and chlordiazepoxide in geriatric patients.  Psychosomatics 9:334-337, 1967. 

Goldstein BJ, Usubiaga JE, Gustafson W, & Moya F:  The effect of intravenous lignocaine on cardiac arrhythmias during electroconvulsive therapy.  British Journal of Anesthesia 39:875-967, 1967. 

Goldstein BJ & Braunstein J: Evaluation of magnesium pemoline as a stimulant in geriatric patients.  Current Therapeutic Research 10(9):457460, 1968. 

Goldstein BJ & Brauzer B: Comparative effects of intramuscular thiothixene and trifluoperazine in psychotic patients.  Journal of Clinical Pharmacology 8:(6):400-403, 1968. 

Goldstein BJ, and Jacobson S:  Clinical evaluation of SKF-14336 in the treatment of psychosis associated with organic brain syndrome. 

Diseases of the Nervous System 30:37-41, 1969. 

Goldstein BJ & Pinosky DG: Clinical evaluation of doxepin in anxious depressed outpatients.  Current Therapeutic Research 11:169-177, 1969. 

Goldstein BJ, Brauzer B, Clyde DJ, & Caldwell JM:  The differential prediction of response to haloperidol and perphenazine.  Psychosomatics 10:(3):193-197, 1969. 

Goldstein BJ, Slater VL, Miller JE, Shea G, Olsen PC, & Jones EA:  Comparison of mesoridazine and chlordiazepoxide in psychoneurotic patients.  Current Therapeutic Research11(11):657-662, 1969. 

Ravel R, Goldstein BJ, & Riekers HG:  Effects of certain psychotropic drugs on immunologic pregnancy tests.  American Journal of Obstetrics and Gynecology 105(8):1222-1225, 1969. 

Goldstein BJ & Weiner D: Clinical evaluation of a new anti-anxiety agent BA30803.  Journal of Clinical Pharmacology and New Drugs 10(1)19-23, 1970. 

Brauzer B & Goldstein BJ: The differential response to parenteral chlorpromazine and mesoridazine in psychotic patients.  Journal of Clinical Pharmacology and New Drugs 10(1):126-131, 1970. 

Goldstein BJ, & Weiner DM:  Comparative evaluation of benzoctamine and diazepam in treatment of anxiety.  Journal of Clinical Pharmacology 10(3):194-198, 1970. 

Goldstein BJ:  Comparative efficacy of thiothixene capsules and concentrate in acutely schizophrenic patients.  Psychosomatics 3(5):434-437, 1971. 

Brauzer B, & Goldstein BJ:  Comparison of molindone and placebo in anxiousdepressed patients.  Current Therapeutic Research 13(6):344-349, 1971. 

Goldstein BJ, Overall JE, & Brauzer B:  Symptomatic volunteers in psychiatric research.  Journal of Psychiatric Research 9:31-43, 1971. 

Goldstein BJ:  Serendipity and armchair reasoning.  Abreaction 2(2):1, 8-9, 1971. 

Brauzer B, Goldstein BJ, Jacobson AF, & Steinbook RM:  The reevaluation of a central nervous system stimulant:  Pipradol hydrochloride.  Current Therapeutic Research 14(12):780-784, 1972. 

Brauzer B, & Goldstein BJ:  Placebo controlled evaluation of phenaglycodol in anxious depressed outpatients.  Journal of Clinical Pharmacology and New Drugs 12(7):280-285, 1972. 

Steinbook RM, Goldstein BJ, Brauzer B, Moreno S, & Jacobson AF:  Loxapine:  A double-blind comparison with chlorpromazine in acute schizophrenic patients. Current Therapeutic Research 15(1):1-7, 1973. 

Brauzer B, & Goldstein BJ:  Symptomatic volunteers - another dimension for clinical trials.  Journal of Clinical Pharmacology and New Drugs 13(2):89-98, 1973. 

Goldstein BJ, & Brauzer B:  Thiothixene in the treatment of anxiety and depression.  Journal of Clinical Pharmacology and New Drugs 13(4):167-178, 1973. 

Goldstein BJ, Brauzer B, Steinbook RM, & Jacobson AF:  Psychotropic drug treatment of mixed anxiety and depression in non-psychiatric office patients.  Southern Medical Journal:66(8):892-897, 1973. 

Goldstein BJ, Brauzer B, Steinbook RM, & Jacobson AF:  Psychotropic drug treatment of mixed anxiety and depression in non-psychiatric office patients.  Psychiatry Digest May:22-24, 1974. 

Brauzer B, Goldstein BJ, Steinbook RM, & Jacobson AF:  The treatment of mixed anxiety and depression with Loxapine:  A controlled comparative study.  Journal of Clinical Pharmacology 14(8,9):455-463, 1974. 

Goldstein BJ, Brauzer B, Steinbook RM, Jacobson AF, & Moreno SS:  Metiapine:  A double-blind comparison with chlorpromazine in acute schizophrenic patients.  Journal of Clinical Pharmacology 15(10):700704, 1975. 

Jacobson AF, Brauzer B, Steinbook RM, & Goldstein BJ:  Doctor-patient concordance on the relative severity of anxiety and depression in symptomatic volunteers.  Psychopharmacology Bulletin,  NIMH 12(2), 1976. 

Jacobson AF, Brauzer B, Goldstein BJ, Steinbook RM, & Weiss BL:  A comparison of doctor and patient rating scales assessing psychopathology in three outpatient samples. Psychopharmacology Bulletin, NIMH 13(2), 1977. 

Weiss BL, Jacobson AF, Steinbook RM, Brauzer B, & Goldstein BJ:  Controlled comparison of trifluoperazine and chlordiazepoxide in the treatment of anxiety.  Current Therapeutic Research 22(5), 1977. 

Goldstein BJ:  Drug therapy for the depressed patient.  Hospital Formulary 12(12):855-861, 1977. 

Jacobson AF, Weiss BL, Steinbook RM, Brauzer B, & Goldstein BJ:  The measurement of psychological states by use of factors derived from a combination of items from mood and symptom checklists.  Journal of Clinical Psychology 34(3), 1978. 

Steinbook RM, Jacobson AF, Weiss BL, & Goldstein BJ:  Amoxapine, imipramine ad placebo:  A double-blind study with pretherapy urinary 3methoxy-4-hydroxphenylglycol levels. Current Therapeutic Research 26(5):490-496, 1979. 

Goldstein BJ & Claghorn JL: An overview of seventeen years of experience with dothiepin in the treatment of depression in Europe.  Journal of Clinical Psychiatry 41(12) (II), 1980. 

Dominguez RA, Jacobson AF, Goldstein BJ, & Steinbook RM:  A placebocontrolled comparison of amoxapine and imipramine in the treatment of depressed outpatients.  Current Therapeutic Research 29(5), 1981. 

Dominguez RA, Jacobson AF, Goldstein BJ, & Steinbook RM:  A crossover comparison of brotizolam and temazepam in the treatment of insomnia. 

Current Therapeutic Research 33(3):372-279, 1983. 

Jacobson AF, Goldstein BJ, Dominguez RA, & Steinbook RM:  A placebocontrolled, double-blind comparison of clobazam and diazepam to the treatment of anxiety.  Journal of Clinical Psychiatry 44(8):296-300, 1983. 

Goldstein BJ, Brauzer B, Kentsmith D, Rosenthal S, & Charalampous KD:  Double-blind placebo-controlled multicenter evaluation of the efficacy and safety of nomifensine in depressed outpatients.  Journal of Clinical Psychiatry 45(4)(II):52-55, 1984. 

Dominguez RA & Goldstein BJ: Beta-blockers in psychiatry.  Hospital and Community Psychiatry 35(6):565-566, 1984. 

Claghorn J, Schroeder J, & Goldstein BJ:  A comparison of the electrocardiographic effect of dothiepin and amitriptyline.  Journal of Clinical Psychiatry 45(7):291-293, 1984. 

Dominguez RA, Jacobson AF, Goldstein BJ, & Steinbook RM:  Comparison of triazolam and placebo in the treatment of insomnia in depressed patients. 

Current Therapeutic Research 36:856-865, 1984. 

Goldstein BJ, Dominguez RA, & Weiss BL:  Amoxapine in psychotic depression.  Journal of Clinical Psychiatry Monograph 3(1):14-16, 1985. 

Dominguez RA, Goldstein BJ, Jacobson AF, & Steinbook RM:  Brotizolam in the treatment of insomnia.  Psychopharmacology Bulletin 21:97-100, 1985. 

Dominguez RA, Goldstein BJ, Jacobson AF, & Steinbook RM:  A doubleblind placebo-controlled study of fluvoxamine and imipramine in depression.  Journal of Clinical Psychiatry46(3):84-87, 1985. 

Dominguez RA, Jacobson AF, Goldstein BJ, & Steinbook RM:  Hypnotic efficacy of brotizolam:  A modified triazolodiazepine.  Clinical Pharmacology and Therapeutics 37(6):674-672, 1985. 

Jacobson AF, Dominguez RA, Goldstein BJ, & Steinbook RM:  Comparative efficacy of buspirone and diazepam in outpatients with generalized anxiety disorder.  Pharmacotherapy5(5):290-296, 1985. 

Dominguez RA & Goldstein BJ:  25 years of benzodiazpeine experience:  Clinical commentary on use, abuse and withdrawal.  Hospital Formulary 20(9):1000-1014, 1985. 

Jacobson AF, Dominguez RA, Goldstein BJ, & Steinbook RM:  Efficacy of brotizolam in geriatric patients with insomnia.  Current Therapeutic Research 39(4):528-536, 1986. 

Dominguez RA, Goldstein BJ, Jacobson AF, & Steinbook RM:  Estazolam in the treatment of insomnia.  Psychopharmacology Bulletin 22(1):278280, 1986. 

Dominguez RA, Jacobson AF, Goldstein BJ, & Steinbook RM:  Comparative efficacy of estazolam, flurazepam and placebo in outpatients with insomnia.  Journal of Clinical Psychiatry47(7):362-365, 1986. 

Jacobson AF, Goldstein BJ, Dominguez RA, & Steinbook RM:  Interrater agreement and interclass reliability measure of SAFTEE in psychopharmacologic clinical trials. Psychopharmacology Bulletin 22(2):382-388, 1986. 

Jacobson AF, Goldstein BJ, Dominguez RA, & Steinbook RM:  Interrater agreement and reliability measures of SAFTEE:  General inquiry versus systematic inquiry.  Abridged Proceedings of the 1986 NCDEU meeting. 

Psychopharmacology Bulletin 23(1), 1987. 

Dominguez RA & Goldstein BJ: The treatment of obsessive-compulsive disorder.  Journal of the Florida Medical Association 75(2), 91-94, 1988. 

Dominguez RA, Jacobson AF, de la Gandara J, Goldstein BJ & Steinbook RM:  Drug response assessed by the modified Maudsley ObsessiveCompulsive Inventory.  Psychopharmacology Bulletin.  25 (2): 215-218, 1989. 

Amin MM, Ananth JV, Coleman BS, Darcourt G, Farkas T, Goldstein BJ, LaPierre YD, Paykel E, & Wakelin JS:  Fluvoxamine:  Antidepressant effects confirmed in a placebo-controlled international study.  Excerpta Medica Foundation Press,1988. 

Dominguez RA & Goldstein BJ:  American experience with the use of Dothiepin, in Expectations in the Treatment of Depressive Illness:  The Rile of Dothiepin. Round Table Series, Royal Society of Medicine Services, 1988. 

Dominguez RA, Goldstein BJ:  Suicidal and Homicidal Ideations Emerging During a Placebo Period.  J. of Clinical Psychiatry.1992.  

Goodnick PJ & Goldstein BJ: Selective Serotonin Reuptake Inhibitors in The Treatment of Affective Disorders I- Basic Pharmacology.  J.

Psychopharmacology. 12(3): 5-20, 1998 

Goldstein BJ & Goodnick PJ: Selective Serotonin reuptake inhibitors in the Treatment of Affective Disorders II - Tolerability Safety, and Pharmacoeconomics. J. Psychopharmacology   12 (3): 21-54, 1998. 

Goldstein BJ & Goodnick PJ: Selective Serotonin Reuptake Inhibitors II Efficacy and Quality of Life.  J. Psychopharmacology . 12 (3):56-89, 1998. 

McBride, D., Terry, Y., Van Buren H., and Goldstein, B.J.: Depression, Drug Use and Health Service Needs. Yearbook of Medical Social Services 2001

 

Burton J. Goldstein

June 16, 2016